The FDA is warning consumers of raw oysters from British Columbia potentially contaminated with norovirus.
The FDA says oysters can cause illness if eaten raw, particularly in people with compromised immune systems.Norovirus can infect people of all ages, and the most common symptoms of infection are diarrhea, vomiting, nausea and stomach pain. Additional symptoms can include fever, headache and body ache.
These symptoms will usually develop 12 to 48 hours after exposure to the virus. People typically recover from norovirus in one to three days. To protect yourself from norovirus infection, the FDA urges you to avoid eating raw oysters in any of the locations listed above. If you have any of the products, the agency recommends throwing them away or returning them to the distributor.Most Read
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA panel to discuss what COVID shots we'll need nextFDA advisers will meet today to discuss what shots we'll need next.
Weiterlesen »
Watchdog urged to probe McKinsey over work with FDA, opioid manufacturersSenate Democrats are calling on a government watchdog to investigate McKinsey & Company over claims that the consulting giant skirted federal conflict-of-interest rules.
Weiterlesen »
Opinion | FDA Shuts Out Its Own Experts in Authorizing Another Vaccine BoosterFrom WSJopinion: Trust in public health is at an all-time low. When agencies bypass their own experts, it only reinforces the perception that health policy is driven by groupthink and politics, writes Marty Makary.
Weiterlesen »
Scientists Divided on Need for 4th Covid Shot After FDA Quietly Approved Another Round of BoostersThe FDA's top vaccine regulator Dr. Peter Marks said shortly after the decision that another round of boosters will likely be needed in the fall.
Weiterlesen »
Current COVID vaccines not 'well-matched' against BA.2 -FDAThe FDA, however, said booster shots protect against serious outcomes of COVID-19, compared with the two preliminary doses. U.S. health officials in late March authorized a second booster dose of Moderna and Pfizer's vaccines for people aged 50 and older, citing data showing waning immunity and risks posed by Omicron variants of the virus. 'This discussion today is a much larger discussion - it's a discussion for what do we do about the entire population, and what do we do when we think the virus has evolved further,' said Peter Marks, director of the FDA's Center for Biologics Evaluation and Research.
Weiterlesen »